EXPO - Exponent Inc Stock Price, Fair Value and News

79.95USD-0.65 (-0.81%)Delayed as of 25 Apr 2024, 10:52 am ET

Market Summary

USD79.95-0.65

Delayedas of 25 Apr 2024, 10:52 am

-0.81%

EXPO Stock Price

View Fullscreen

EXPO RSI Chart

EXPO Valuation

Market Cap

4.1B

Price/Earnings (Trailing)

40.62

Price/Sales (Trailing)

7.59

EV/EBITDA

26.85

Price/Free Cashflow

36.72

EXPO Price/Sales (Trailing)

EXPO Profitability

EBT Margin

25.32%

Return on Equity

28.18%

Return on Assets

15.51%

Free Cashflow Yield

2.72%

EXPO Fundamentals

EXPO Revenue

Revenue (TTM)

536.8M

Rev. Growth (Yr)

-3.5%

Rev. Growth (Qtr)

-7.83%

EXPO Earnings

Earnings (TTM)

100.3M

Earnings Growth (Yr)

-7.08%

Earnings Growth (Qtr)

-14.71%

Breaking Down EXPO Revenue

52 Week Range

79.55101.66

(Low)(High)

Last 7 days

3.7%

Last 30 days

1.9%

Last 90 days

-9.1%

Trailing 12 Months

-15.3%

How does EXPO drawdown profile look like?

EXPO Financial Health

Current Ratio

2.34

EXPO Investor Care

Dividend Yield

1.29%

Dividend/Share (TTM)

1.04

Buy Backs (1Y)

0.16%

Diluted EPS (TTM)

1.94

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	525.1M	535.1M	541.2M	536.8M
2022	478.3M	488.7M	499.4M	513.3M
2021	410.4M	438.3M	456.0M	466.3M
2020	424.1M	409.7M	406.8M	399.9M
2019	382.1M	393.0M	399.2M	417.2M
2018	360.1M	367.9M	375.7M	379.5M
2017	316.0M	326.6M	336.5M	347.8M
2016	315.7M	313.1M	311.7M	315.1M
2015	309.0M	312.3M	312.8M	312.8M
2014	299.5M	300.5M	303.9M	304.7M
2013	293.4M	294.4M	296.3M	296.2M
2012	270.9M	280.3M	287.6M	292.7M
2011	262.8M	267.5M	267.1M	272.4M
2010	0	234.8M	241.8M	248.8M
2009	0	0	0	227.9M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Exponent Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 13, 2024	reiss richard	acquired	-	-	2,660	group vice president
Mar 13, 2024	reiss richard	sold (taxes)	-104,003	78.79	-1,320	group vice president
Mar 13, 2024	corrigan catherine	acquired	-	-	12,410	president & ceo
Mar 13, 2024	shepard sally	acquired	-	-	5,320	chief human resources officer
Mar 13, 2024	pye john	acquired	-	-	592	group vice president
Mar 13, 2024	schlenker richard l jr	sold (taxes)	-338,088	78.79	-4,291	evp & chief financial officer
Mar 13, 2024	james bradley a	sold (taxes)	-163,410	78.79	-2,074	group vice president
Mar 13, 2024	rakow joseph	acquired	-	-	3,546	group vice president
Mar 13, 2024	corrigan catherine	sold (taxes)	-473,370	78.79	-6,008	president & ceo
Mar 13, 2024	james bradley a	acquired	-	-	6,206	group vice president

Which funds bought or sold EXPO recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 23, 2024	NEW MEXICO EDUCATIONAL RETIREMENT BOARD	unchanged	-	-55,000	852,000	0.03%
Apr 23, 2024	AMALGAMATED BANK	reduced	-16.94	-618,000	2,193,000	0.02%
Apr 23, 2024	Louisiana State Employees Retirement System	added	2.82	-42,894	1,207,270	0.02%
Apr 23, 2024	Venturi Wealth Management, LLC	unchanged	-	-1,653	25,552	-%
Apr 23, 2024	FIFTH THIRD BANCORP	added	163	249,937	419,238	-%
Apr 23, 2024	Global Retirement Partners, LLC	reduced	-32.54	-4,410	6,990	-%
Apr 23, 2024	RICE HALL JAMES & ASSOCIATES, LLC	added	0.14	-162,268	2,566,530	0.15%
Apr 23, 2024	REGIONS FINANCIAL CORP	reduced	-1.94	-30,413	354,410	-%
Apr 22, 2024	Oakworth Capital, Inc.	unchanged	-	-187	2,894	-%
Apr 22, 2024	MetLife Investment Management, LLC	reduced	-1.05	82,579	4,752,490	0.03%

Are Funds Buying or Selling EXPO?

Are funds buying EXPO calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own EXPO

No. of Funds

Unveiling Exponent Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 10, 2024	vanguard group inc	10.46%	5,286,652	SC 13G/A
Feb 13, 2024	vanguard group inc	9.87%	4,995,605	SC 13G/A
Feb 13, 2024	kayne anderson rudnick investment management llc	9.23%	4,672,271	SC 13G/A
Feb 12, 2024	neuberger berman group llc	5.20%	2,630,411	SC 13G/A
Jan 23, 2024	blackrock inc.	12.0%	6,079,135	SC 13G/A
Jan 05, 2024	conestoga capital advisors, llc	5.13%	2,596,177	SC 13G/A
Feb 14, 2023	kayne anderson rudnick investment management llc	8.23%	4,168,554	SC 13G/A
Feb 10, 2023	neuberger berman group llc	5.72%	2,897,828	SC 13G/A
Feb 09, 2023	vanguard group inc	11.07%	5,606,880	SC 13G/A
Jan 26, 2023	blackrock inc.	15.8%	8,010,803	SC 13G/A

Recent SEC filings of Exponent Inc

View All Filings

Date Filed	Form Type	Document
Apr 22, 2024	ARS	ARS
Apr 22, 2024	DEF 14A	DEF 14A
Apr 22, 2024	DEFA14A	DEFA14A
Apr 17, 2024	10-K/A	Annual Report
Apr 10, 2024	SC 13G/A	Major Ownership Report
Mar 25, 2024	3	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 19, 2024	4	Insider Trading

Peers (Alternatives to Exponent Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
CAT	185.5B	67.1B	2.08%	66.19%	17.96	2.77	12.84%	54.12%
GE	174.3B	69.5B	-8.20%	61.78%	49.65	2.51	16.04%	-60.91%
CMI	41.5B	34.1B	1.63%	25.27%	49.39	1.22	21.34%	-61.52%
AME	41.2B	6.6B	-2.45%	31.17%	31.36	6.24	7.26%	13.25%
ACM	12.8B	14.9B	-1.92%	15.25%	206.83	0.86	12.31%	-81.65%
MID-CAP
APG	9.2B	6.9B	-3.15%	70.81%	59.86	1.32	5.64%	109.59%
FLR	6.9B	15.5B	-1.08%	39.69%	49.58	0.44	12.59%	-4.48%
FLS	6.1B	4.3B	2.61%	43.21%	32.84	1.42	19.51%	-1.03%
ACA	3.7B	2.3B	-8.62%	30.99%	23.46	1.62	2.90%	-35.23%
ALG	2.5B	1.7B	-5.66%	15.00%	18.02	1.45	11.63%	33.59%
SMALL-CAP
AMRC	1.1B	1.4B	8.23%	-51.08%	17.77	0.81	-24.65%	-34.19%
NKLA	828.1M	35.8M	-16.22%	-23.98%	-0.86	23.11	-27.93%	-23.21%
AGX	811.8M	573.3M	21.26%	53.51%	25.09	1.42	26.00%	-2.24%
AMSC	364.8M	135.4M	-10.08%	199.75%	-22.24	2.7	-25.90%	65.37%
ADES	245.0M	99.2M	11.50%	304.95%	-20	2.47	-3.69%	-37.37%

Exponent Inc News

Latest updates

Exponent Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-7.8%	123	133	140	140	127	127	130	128	114	116	120	116	103	99.00	92.00	106	110	102	107	99.00	92.00
Operating Expenses	5.1%	105	99.00	110	111	105	90.00	85.00	92.00	90.00	84.00	91.00	92.00	86.00	78.00	83.00	70.00	89.00	78.00	82.00	83.00	65.00
S&GA Expenses	-1.3%	6.00	6.00	7.00	6.00	7.00	7.00	6.00	4.00	5.00	4.00	3.00	3.00	2.00	3.00	3.00	6.00	5.00	5.00	5.00	5.00	4.00
EBITDA Margin	0.9%	0.27*	0.27*	0.27*	0.27*	0.27*	0.27*	0.28*	0.28*	0.28*	0.29*	0.28*	0.27*	-	-	-	-	-	-	-	-	-
Income Taxes	-3.4%	9.00	9.00	11.00	6.00	8.00	9.00	10.00	3.00	8.00	8.00	9.00	-0.72	5.00	7.00	5.00	-2.23	8.00	6.00	8.00	1.00	6.00
Earnings Before Taxes	-11.6%	30.00	34.00	36.00	36.00	31.00	33.00	35.00	33.00	29.00	32.00	35.00	30.00	27.00	25.00	21.00	24.00	27.00	25.00	29.00	23.00	22.00
EBT Margin	0.5%	0.25*	0.25*	0.25*	0.26*	0.26*	0.26*	0.26*	0.27*	0.27*	0.27*	0.27*	0.25*	-	-	-	-	-	-	-	-	-
Net Income	-14.7%	21.00	25.00	26.00	29.00	23.00	24.00	26.00	30.00	20.00	25.00	25.00	31.00	22.00	18.00	16.00	26.00	19.00	20.00	21.00	23.00	16.00
Net Income Margin	-0.7%	0.19*	0.19*	0.19*	0.19*	0.20*	0.20*	0.21*	0.21*	0.22*	0.23*	0.22*	0.21*	-	-	-	-	-	-	-	-	-
Free Cashflow	267.2%	69.00	19.00	35.00	-12.37	38.00	26.00	27.00	-8.96	53.00	24.00	42.00	-1.23	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	7.4%	647	602	604	566	587	559	567	618	684	638	619	577	580	535	513	484	563	544	521	489	469
Current Assets	10.5%	380	343	345	318	349	333	343	377	453	418	398	354	367	329	314	293	364	352	335	305	327
Cash Equivalents	36.5%	187	137	148	126	161	148	166	215	298	230	240	185	198	188	156	106	176	133	104	79.00	127
Net PPE	-1.2%	75.00	76.00	77.00	69.00	66.00	64.00	64.00	61.00	60.00	60.00	60.00	60.00	60.00	60.00	60.00	61.00	62.00	59.00	56.00	51.00	46.00
Goodwill	0%	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00	9.00
Liabilities	16.8%	291	249	247	225	266	239	229	231	267	233	231	199	219	191	181	160	213	187	177	160	155
Current Liabilities	24.9%	162	130	125	109	159	138	128	109	153	126	123	88.00	117	96.00	90.00	77.00	124	101	93.00	72.00	98.00
Shareholder's Equity	0.7%	356	354	357	342	321	320	337	387	417	405	388	378	361	343	333	323	350	357	344	329	314
Retained Earnings	1.3%	574	567	555	543	529	519	507	493	478	469	455	440	422	410	402	396	385	374	363	351	342
Additional Paid-In Capital	0.4%	321	320	317	315	301	299	296	294	281	279	276	274	265	262	260	257	245	243	241	239	227
Accumulated Depreciation	-5.0%	104	109	-	-	103	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares Outstanding	-0.1%	51.00	51.00	51.00	51.00	52.00	52.00	52.00	52.00	53.00	53.00	53.00	53.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	3,400	-	-	-	3,400	-	-	-	3,446	-	-	-	3,092	-	-	-	2,245	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	221.2%	71,309	22,201	40,545	-6,703	40,570	29,421	30,168	-6,352	54,190	24,926	44,167	1,285	40,865	28,248	48,034	-13,835	55,766	27,474	37,072	-12,253	44,362
Share Based Compensation	-35.0%	3,180	4,891	5,223	7,063	4,292	4,605	4,597	6,870	4,024	4,365	4,592	6,282	3,952	3,726	3,462	6,138	3,881	3,844	4,010	5,731	3,388
Cashflow From Investing	41.5%	-1,934	-3,306	-5,448	-5,668	-2,935	-3,194	-3,308	-2,606	23,609	-26,188	28,269	12,488	-25,832	12,323	10,826	7,707	15,986	8,470	-3,669	-16,518	-3,862
Cashflow From Financing	32.3%	-20,037	-29,578	-12,654	-23,740	-25,421	-42,020	-75,128	-73,408	-9,987	-8,769	-16,971	-27,026	-6,120	-9,329	-8,582	-64,324	-28,977	-7,200	-7,822	-19,415	-34,229
Dividend Payments	-0.2%	13,149	13,177	13,217	14,500	12,153	12,225	12,345	12,514	10,423	10,421	10,419	11,935	9,839	9,808	9,820	10,308	8,280	8,324	8,306	8,593	6,723
Buy Backs	-57.3%	7,238	16,970	-	-	13,446	30,783	63,289	48,554	-	-	7,000	-	-	-	-	40,049	-	-	-	-	27,915

EXPO Income Statement

2023-12-29

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 29, 2023	Dec. 30, 2022	Dec. 31, 2021
Revenues:
Revenues before reimbursements	$ 497,189	$ 463,820	$ 434,850
Reimbursements	39,577	49,473	31,419
Revenues	536,766	513,293	466,269
Operating expenses:
Compensation and related expenses	319,886	264,235	278,047
Other operating expenses	41,541	35,083	32,594
Reimbursable expenses	39,577	49,473	31,419
General and administrative expenses	24,440	23,660	15,282
Total operating expenses	425,444	372,451	357,342
Operating income	111,322	140,842	108,927
Other income:
Interest income	7,150	2,096	66
Miscellaneous income, net	17,424	(10,704)	16,844
Income before income taxes	135,896	132,234	125,837
Provision for income taxes	35,557	29,904	24,635
Net income	$ 100,339	$ 102,330	$ 101,202
Net income per share:
Basic (in dollars per share)	$ 1.96	$ 1.98	$ 1.92
Diluted (in dollars per share)	$ 1.94	$ 1.96	$ 1.9
Shares used in per share computations:
Basic (in shares)	51,152	51,727	52,610
Diluted (in shares)	51,635	52,280	53,331
Cash dividends declared per common share (in dollars per share)	$ 1.04	$ 0.96	$ 0.8

EXPO Balance Sheet

2023-12-29

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 29, 2023	Dec. 30, 2022
Current assets:
Cash and cash equivalents	$ 187,150	$ 161,458
Accounts receivable, net of allowance for contract losses and doubtful accounts of $5,281 and $6,193, respectively	167,360	170,114
Prepaid expenses and other current assets	25,022	17,585
Total current assets	379,532	349,157
Property, equipment and leasehold improvements, net	75,318	65,539
Operating lease right-of-use assets	24,600	18,007
Goodwill	8,607	8,607
Deferred income taxes	53,824	53,909
Deferred compensation plan assets	101,169	89,437
Other assets	3,727	2,006
Total assets	646,777	586,662
Current liabilities:
Accounts payable and accrued liabilities	22,125	29,115
Accrued payroll and employee benefits	111,773	105,822
Deferred revenues	21,709	18,834
Operating lease liabilities	6,302	5,258
Total current liabilities	161,909	159,029
Other liabilities	3,426	2,355
Deferred compensation plan liabilities	103,398	91,183
Operating lease liabilities	21,959	13,343
Total liabilities	290,692	265,910
Commitments and contingencies (Note 13)
Stockholders’ equity:
Preferred stock, $0.001 par value; 2,000 shares authorized; no shares outstanding
Common stock, $0.001 par value; 120,000 shares authorized; 65,707 shares issued	66	66
Additional paid-in capital	321,448	301,002
Accumulated other comprehensive income/(loss)
Foreign currency translation adjustments	(2,977)	(3,587)
Retained earnings	574,082	528,810
Treasury stock, at cost: 15,134 and 15,064 shares held, respectively	(536,534)	(505,539)
Total stockholders’ equity	356,085	320,752
Total liabilities and stockholders’ equity	$ 646,777	$ 586,662

About Exponent Inc

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

CEO	Dr. Catherine Ford Corrigan P.E., Ph.D.
WEBSITE	exponent.com
INDUSTRY	Apparel Manufacturing
EMPLOYEES	1077

Exponent Inc Frequently Asked Questions

What is the ticker symbol for Exponent Inc? What does EXPO stand for in stocks?

EXPO is the stock ticker symbol of Exponent Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Exponent Inc (EXPO)?

As of Wed Apr 24 2024, market cap of Exponent Inc is 4.08 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of EXPO stock?

You can check EXPO's fair value in chart for subscribers.

What is the fair value of EXPO stock?

You can check EXPO's fair value in chart for subscribers. The fair value of Exponent Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Exponent Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for EXPO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Exponent Inc a good stock to buy?

The fair value guage provides a quick view whether EXPO is over valued or under valued. Whether Exponent Inc is cheap or expensive depends on the assumptions which impact Exponent Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EXPO.

What is Exponent Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Apr 24 2024, EXPO's PE ratio (Price to Earnings) is 40.62 and Price to Sales (PS) ratio is 7.59. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. EXPO PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Exponent Inc's stock?

In the past 10 years, Exponent Inc has provided 0.176 (multiply by 100 for percentage) rate of return.